Mazabraud syndrome is a rare condition in which people have areas of abnormal bone growth and soft tissue lumps called myxomas. Many living with Mazabraud syndrome have bone pain, swelling, limping, or a painless lump, and the early symptoms of Mazabraud syndrome can be mild at first. It is usually recognized in adults, especially women, though the timing and features can vary. Not everyone will have the same experience, but Mazabraud syndrome is usually long-lasting and it is not generally thought to shorten life on its own. Treatment for Mazabraud syndrome often focuses on monitoring, pain relief, and surgery when bone problems or myxomas cause symptoms or limit movement.
How many people live with Mazabraud syndrome?
Mazabraud syndrome is so rare that a reliable worldwide estimate of how many people are living with it is not consistently reported by a single major source; Orphanet lists it as an ultra-rare disorder, but does not provide a current global count (Orphanet, 2024). A separate United States estimate is also not consistently reported, and the Genetic and Rare Diseases Information Center says the exact number of people living with it is unknown (Genetic and Rare Diseases Information Center, 2024).
Overview
Mazabraud syndromeSymptoms
Mazabraud syndrome often causes painless soft-tissue lumps near bones and bone pain, swelling, or limping. Many living with Mazabraud syndrome have fibrous dysplasia, which can weaken bone and sometimes lead to fractures.
Outlook and prognosis
Mazabraud syndrome often follows a slow, manageable course. Many living with Mazabraud syndrome do well with monitoring and treatment for painful bone changes or soft-tissue lumps. Outlook depends mainly on how much fibrous dysplasia affects strength, pain, and fracture risk.
Causes and risk factors
Mazabraud syndrome is usually caused by a random, early-life change in the GNAS gene. It is not usually inherited. No clear lifestyle or environmental risk factors are known, though symptoms can vary depending on which tissues carry the gene change.
Genetic influences
Genetics matter in Mazabraud syndrome, but it is usually not inherited. Many cases are linked to a change in the GNAS gene that happens after conception, so family members are rarely affected.
Diagnosis
Diagnosis of Mazabraud syndrome usually starts with imaging such as X-rays or MRI or CT scans. Doctors look for the typical pattern of bone changes and soft tissue lumps. A biopsy and, at times, genetic tests can help confirm it.
Treatment and drugs
Treatment for Mazabraud syndrome focuses on symptoms and bone safety. Painful fibrous dysplasia may be managed with pain medicines, sometimes bisphosphonates, and surgery for fractures or deformity. Soft-tissue myxomas are usually removed only if bothersome or growing.
Symptoms
Many people with Mazabraud syndrome notice day-to-day problems such as a deep ache in one bone, a limp, or a soft lump in a nearby muscle. These changes often affect the legs, hips, or pelvis, though other bones and muscles can be involved. The early features of Mazabraud syndrome can be mild, so they are sometimes mistaken for a strain or ordinary joint pain. Features vary from person to person and can change over time.
Affected bones can ache deeply or hurt more with walking, standing, or exercise. In Mazabraud syndrome, this pain often comes from areas of weakened, abnormal bone.
Many people with Mazabraud syndrome develop soft, slow-growing lumps in a muscle, often near an affected bone. These lumps are usually painless, but they can cause a feeling of fullness or become noticeable during daily activities.
Some people develop swelling, bowing, or other visible changes in the shape of a limb. Over time, this can affect balance, posture, or the way weight is carried.
When the hips, pelvis, or leg bones are involved, walking may become uneven and nearby joints can feel stiff or sore. Everyday tasks like climbing stairs or getting up from a chair may take more effort.
How people usually first notice Mazabraud syndrome?
Many people first notice Mazabraud syndrome because of a slowly growing, painless lump in a muscle, often in the thigh, buttock, upper arm, or shoulder, or because of bone pain that keeps coming back. In others, the first signs of Mazabraud syndrome are a limp, swelling, repeated fractures, or one arm or leg seeming more bowed or shaped differently because of fibrous dysplasia, a condition where part of a bone develops abnormally and becomes weaker than usual. Sometimes the condition is first found after an X-ray, MRI, or scan done for pain, an injury, or an unexpected soft-tissue mass, and doctors then realize the muscle lump and bone changes are linked.
Types of Mazabraud syndrome
No distinct types of Mazabraud syndrome are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay when symptoms of Mazabraud syndrome begin. Because this is a rare condition tied to abnormal growth in bone and nearby soft tissue, things like diet, exercise, sleep, or supplements have not been shown to prevent it, although staying generally healthy is still good for your overall well-being; regular checkups and scans may help find bone pain, fractures, or new lumps early, but they do not stop the condition from starting. Even so, early monitoring and treatment can still help many people living with Mazabraud syndrome manage problems sooner and more comfortably.
What genetics can tell you about symptoms
In Mazabraud syndrome, genetic changes that happen after conception, most often in a gene called GNAS, are thought to drive both the bone changes and the soft-tissue lumps that can appear nearby. Genetics can help explain why the condition happens, but at this point it usually cannot predict exactly which symptoms someone will have, how painful or extensive they will be, or when they will start, because symptoms vary widely from one person to another. These gene changes are usually not inherited from a parent, so the results are more helpful for confirming the diagnosis than for forecasting day-to-day symptoms.
Causes and risk factors
Mazabraud syndrome most often happens because of a change in the GNAS gene that appears early in development. This change is usually new and not inherited, so family history is not a common risk factor. The main biological risk is having fibrous dysplasia, especially when it affects several bones. Having a gene change doesn’t mean you’ll definitely develop the condition, and no clear lifestyle or environmental causes have been proven. Doctors may watch for early symptoms of Mazabraud syndrome more closely in people living with fibrous dysplasia.
What are the most common causes or risk factors?
Mazabraud syndrome is usually linked to a random change in a gene called GNAS that happens early in development, so it is not something a parent passes down and it is not caused by anything you did. The clearest risk factor is already having fibrous dysplasia, a condition where some bones grow in an unusual way, because the soft-tissue lumps seen in this syndrome often develop near those affected bones. It is also reported more often in women, and there are no known lifestyle risk factors such as diet, exercise, or environmental exposures.
Environmental and biological risk factors
Clear risk factors for Mazabraud syndrome are not well defined because the condition is very rare. Doctors often group risks into internal (biological) and external (environmental). For Mazabraud syndrome, the strongest links are body-based patterns, while outside triggers have not been clearly confirmed.
Mazabraud syndrome is much more likely in people who already have fibrous dysplasia. The soft-tissue growths linked with the syndrome often appear in muscles close to the affected bones.
Risk seems higher when fibrous dysplasia involves more than one bone rather than a single area. Many reported cases of Mazabraud syndrome follow this broader bone pattern.
Reported cases are more common in females than in males. This is a pattern seen in case series, not a guarantee that women will develop the condition or that men cannot.
Mazabraud syndrome is often recognized in adulthood, sometimes years after bone changes first begin. This likely reflects when the muscle growths become noticeable rather than proving age itself is a cause.
Genetic risk factors
When people ask about the genetic causes of Mazabraud syndrome, the main answer is a change in a gene called GNAS. This change affects growth signaling in certain cells and is usually present in only part of the body rather than in every cell. Because of that, Mazabraud syndrome is almost always sporadic, meaning it usually begins by chance after conception instead of being inherited from a parent.
GNAS change: Most cases are linked to an activating change in the GNAS gene. This gene helps control cell signaling, so the change can lead to abnormal growth in bone and nearby soft tissues.
After conception: The gene change usually happens after conception, during early development. That means it is not typically present in the egg or sperm and is not usually passed down through families.
Mosaic pattern: Only some cells carry the GNAS change, a pattern called mosaicism. This helps explain why Mazabraud syndrome may affect certain bones or muscles while other areas remain unaffected.
Shared gene link: The same GNAS change is often found in both fibrous dysplasia and the soft-tissue lumps called myxomas. This shared genetic link helps explain why these two problems can occur together in Mazabraud syndrome.
Family history: A family history of Mazabraud syndrome is uncommon. Close relatives are usually not thought to have a high genetic risk, although unusual family patterns deserve medical review.
Lifestyle risk factors
Mazabraud syndrome is not caused by lifestyle habits, but daily choices can influence pain, mobility, fracture risk, and recovery. Because the condition often involves fibrous dysplasia in bone and intramuscular myxomas in soft tissue, how lifestyle affects Mazabraud syndrome is mainly through mechanical stress, bone health, and symptom control. The most relevant lifestyle risk factors for Mazabraud syndrome are the ones that increase stress on weakened bone or make function harder to maintain.
Repeated jumping, sprinting, contact sports, or heavy loading can place extra stress on bones affected by fibrous dysplasia. This may raise the chance of pain, stress injury, or fracture in vulnerable areas.
Avoiding movement completely can lead to muscle weakness, joint stiffness, and poorer balance around painful or affected limbs. That can reduce mobility and make everyday function harder despite the need to protect fragile bone.
Higher body weight increases load across weight-bearing bones that may already be structurally weaker from fibrous dysplasia. This can worsen pain with walking or standing and may add to fracture risk over time.
Smoking is linked to poorer bone quality, slower tissue healing, and worse circulation. In someone with Mazabraud syndrome, this may complicate recovery after fractures or orthopedic procedures and can make musculoskeletal symptoms harder to manage.
Risk prevention
Mazabraud syndrome cannot usually be prevented because it develops from a change in body cells that happens by chance, rather than from something you did or did not do. For many living with Mazabraud syndrome, prevention is really about lowering the risk of complications such as fractures, worsening bone pain, or problems caused by growing soft-tissue lumps. Prevention works best when combined with regular check-ups. This also helps doctors spot changes early, including early symptoms of Mazabraud syndrome that may need treatment.
Ongoing visits with a bone specialist or other experienced doctor can help track bone changes and soft-tissue lumps over time. Imaging and exams may catch problems before they lead to a fracture, nerve pressure, or loss of movement.
Bones affected by fibrous dysplasia can be weaker than usual, so reducing falls and avoiding high-impact strain may help protect them. Supportive footwear, safer home setups, and activity plans matched to your bone strength can all lower injury risk.
Gentle, regular movement can help keep muscles strong and joints flexible without overloading fragile areas. A physical therapist can help choose lower-impact options if walking, stairs, or lifting starts to trigger pain.
New or worsening pain should be checked rather than pushed through, especially if it comes on suddenly or changes how you walk. Early evaluation can help find a stress injury, fracture, or enlarging lump before it becomes a bigger problem.
Can you prevent Mazabraud syndrome?
No, there is no known way to prevent Mazabraud syndrome. It is thought to happen because of a random gene change in some body cells early in development, so it is not something you can prevent with diet, exercise, or other lifestyle steps. It also usually does not run in families.
Transmission
Mazabraud syndrome is not infectious, so it cannot be caught from someone else through touch, coughing, sex, food, or shared spaces. In most people, Mazabraud syndrome happens because of a random change in a gene called GNAS that occurs after conception in only some cells of the body.
This means how Mazabraud syndrome is inherited is different from many other genetic conditions: it is usually sporadic, with no family history, rather than passed directly from parent to child. Because the gene change is usually not present in every cell, including the egg or sperm cells, the chance of passing Mazabraud syndrome on is thought to be very low.
When to test your genes
For Mazabraud syndrome, gene testing is usually not the first step. If imaging or biopsy shows fibrous dysplasia and intramuscular myxomas, testing the affected tissue for a GNAS change can sometimes help confirm the diagnosis, especially in unusual cases. Blood testing for relatives is not usually helpful because this condition is typically not inherited.
Diagnosis
Mazabraud syndrome is usually suspected when someone has both bone changes from fibrous dysplasia and soft, slow-growing lumps in nearby muscles called myxomas. For many, the first step comes when everyday activities start feeling harder, such as walking with a limp, dealing with ongoing bone pain, or noticing a painless lump in the thigh or arm. The diagnosis of Mazabraud syndrome usually comes from putting together the exam, imaging findings, and sometimes a tissue sample.
Doctors ask about bone pain, swelling, fractures, and when any muscle lumps first appeared. A detailed family and health history can help show whether the pattern fits Mazabraud syndrome and whether another bone condition is more likely.
The exam looks for tender or enlarged areas of bone, differences in limb shape, and soft tissue masses under the skin. Doctors also check movement, gait, and signs that a bone may be weakened.
X-rays often show the typical bone changes of fibrous dysplasia, such as areas that look expanded or have a hazy appearance. These imaging findings can point strongly toward Mazabraud syndrome when they are seen near an intramuscular mass.
MRI is especially helpful for looking at myxomas in the muscles and showing their size and exact location. It can also help tell a likely benign myxoma from other soft tissue tumors and guide where to biopsy if needed.
How is Mazabraud syndrome diagnosed?
Mazabraud syndrome is usually diagnosed when doctors find the typical combination of areas of abnormal bone growth and one or more soft, usually harmless lumps in the muscles. They often use imaging tests such as X-rays to look at the bones and MRI scans to check the muscle lumps, and a small tissue sample called a biopsy may be done to confirm what the lump is and rule out cancer. Genetic testing can sometimes find a change in a gene linked to this condition, but the diagnosis is mainly based on the person’s symptoms, exam, and imaging results.
Stages of Mazabraud syndrome
Mazabraud syndrome does not have defined progression stages. This is because it is usually identified by a pattern of findings, mainly fibrous dysplasia in bone together with soft tissue lumps called myxomas, rather than a steady stage-by-stage worsening over time. Often the process begins when you notice changes in daily life, such as ongoing bone pain, a limp, swelling, or a painless lump near a muscle, and doctors then use imaging scans and sometimes a biopsy to confirm how Mazabraud syndrome is diagnosed. Follow-up usually focuses on watching bone symptoms, checking for fractures or changes in affected bones, and tracking whether myxomas are growing or causing discomfort.
Outlook and prognosis
The outlook for people with Mazabraud syndrome is generally favorable, because the intramuscular myxomas are benign and the fibrous dysplasia often follows a chronic but manageable course. Long-term health is influenced mainly by how extensive the bone involvement is, since fibrous dysplasia can lead to pain, fractures, deformity, or reduced mobility in some individuals. The soft-tissue myxomas may recur after surgical removal, but they do not typically spread to other parts of the body. Overall life expectancy is usually near normal, and mortality from Mazabraud syndrome itself is rare. A small risk of malignant transformation has been reported in the fibrous dysplasia component, especially in people previously exposed to radiation, so ongoing clinical follow-up is important.
Long-term effects
For many living with Mazabraud syndrome, the biggest long-term issues are often bone pain, weak areas in bone, and slow changes in how the body moves and bears weight. The condition combines fibrous dysplasia in bone with soft-tissue lumps called intramuscular myxomas, so its long-term effects can involve both the skeleton and nearby muscles. Long-term effects vary widely, and some people have mild, stable problems while others develop more noticeable limits over time.
Ongoing aching or deep soreness in an arm, leg, rib, or hip can persist for years in Mazabraud syndrome. Pain may be worse after standing, walking, or other everyday activity, and it can come and go rather than stay constant.
Areas of fibrous dysplasia can make bone less sturdy than usual and more likely to crack or break. For many, this can mean repeat fractures or stress fractures, sometimes after only minor strain.
Over time, affected bones may bend, enlarge, or heal in an uneven way. This can lead to limb length differences, a limp, or changes in posture, especially when the legs or pelvis are involved.
Pain, bone weakness, and deformity can make walking long distances, climbing stairs, or standing for long periods harder. In adults, the long-term effects of Mazabraud syndrome may include reduced mobility and less endurance for daily routines.
How is it to live with Mazabraud syndrome?
Living with Mazabraud syndrome often means balancing long stretches of ordinary life with the unpredictability of bone pain, swelling, a limp, or limited movement from fibrous dysplasia, along with soft-tissue lumps called intramuscular myxomas that may feel uncomfortable or worrying even when they are benign. For many people, this can mean adjusting exercise, work, or daily routines, especially if there is pain, fatigue, or a higher risk of fractures in an affected bone. Family members and other close supporters may help with appointments, surgery recovery, or practical tasks during painful periods, but with monitoring and the right care, many people with Mazabraud syndrome are able to maintain active, meaningful daily lives.
Treatment and drugs
Treatment for Mazabraud syndrome is mainly based on symptoms, since there is no medicine that cures the condition itself. Many people living with Mazabraud syndrome are treated with pain relief, physical therapy, and monitoring of the affected bones and soft-tissue lumps, while surgery may be used if a lump is painful, growing, limiting movement, or if weakened bone raises the risk of fracture. Doctors sometimes recommend a combination of lifestyle changes and drugs, especially when bone pain from fibrous dysplasia is a major issue; in some cases, bone-strengthening medicines called bisphosphonates may help reduce pain, though they do not remove the underlying changes. Not every treatment works the same way for every person, so care is usually tailored to where the lesions are, how severe symptoms are, and whether there have been problems such as repeated fractures or trouble walking.
Can you cure Mazabraud syndrome?
No, Mazabraud syndrome cannot currently be cured. Treatment focuses on managing problems it can cause, such as bone pain, broken bones, changes in bone shape, or soft tissue lumps, and this may include regular checkups, pain relief, and sometimes surgery. Many people living with Mazabraud syndrome can still do well with ongoing care that aims to ease symptoms and prevent complications.
Non-drug treatment
Mazabraud syndrome can affect comfort, movement, and day-to-day activities, especially when bone changes or soft-tissue lumps cause pain or limit how easily you walk, lift, or exercise. Treatment usually focuses on monitoring the condition, protecting bone health and function, and dealing with symptoms without relying only on medicine. Managing this condition often involves a team that may include orthopedics, physical therapy, radiology, and sometimes rehabilitation specialists. Because symptoms and bone involvement can vary, care is usually tailored to the areas causing the most trouble.
Follow-up visits and imaging help track bone lesions and soft-tissue myxomas over time. This can show whether a lump is stable, whether bone is weakening, or whether a fracture risk is rising.
Physical therapy can help maintain strength, joint movement, balance, and safer walking patterns when pain or bone changes make movement harder. Some strategies can slip naturally into your routine—like guided stretching, muscle strengthening, and pacing activities to avoid flare-ups.
Adjusting sports, work tasks, or repetitive movements can lower stress on weakened bones and reduce pain. For many, treatment begins not at the pharmacy, but with small changes such as avoiding high-impact exercise and planning rest breaks on busy days.
Braces, shoe inserts, or other supports may help improve alignment and make walking or standing more comfortable. These can be useful if fibrous dysplasia affects a leg or causes uneven strain across a joint.
Your genes may have an impact on how drugs work for you
For people living with Mazabraud syndrome, treatment is usually aimed at easing bone pain, lowering the chance of bone problems, or removing bothersome soft-tissue lumps, and there is no well-established evidence that inherited genetic differences clearly change how the commonly used medicines work. The gene change linked to this condition is usually found only in the affected bone or muscle tissue, not throughout the whole body, so it is not currently used to choose pain medicines or other routine treatments. In everyday care, this means doctors usually pick treatment based on symptoms, scan results, side effects, and how well the person responds over time, rather than using genetic drug testing.
Pharmacological treatments
For many living with Mazabraud syndrome, medicines are used mainly to ease bone pain and reduce complications linked to the fibrous dysplasia part of the condition. There is no drug that cures Mazabraud syndrome itself, and medicines do not reliably remove the soft-tissue lumps called myxomas. Drug treatments are usually chosen based on symptoms, especially ongoing pain, fracture risk, and how active the bone disease appears on scans.
Acetaminophen and nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen are often used for day-to-day pain. They can help with mild to moderate discomfort, but they do not treat the underlying bone changes in Mazabraud syndrome.
Pamidronate, zoledronic acid, and sometimes alendronate are the main drugs used when fibrous dysplasia causes significant bone pain. Many people find relief when the right medicine lowers bone turnover, and these drugs are the most established treatment for bone pain in Mazabraud syndrome.
Denosumab may be considered in selected severe cases when pain remains difficult to control or bisphosphonates are not suitable. Its effects can be strong but temporary, and careful monitoring is needed because calcium levels and bone activity can shift after treatment stops.
Calcium and vitamin D may be recommended if levels are low, especially before or during treatment with bisphosphonates or denosumab. These supplements do not treat Mazabraud syndrome directly, but they help support safer bone-focused treatment.
Genetic influences
Many living with Mazabraud syndrome want to know whether it was something they inherited. Mazabraud syndrome is caused by a change in the GNAS gene. This change usually happens after conception, so it is present in only some cells of the body, which is why doctors call it mosaic. If you are wondering whether Mazabraud syndrome runs in families, the answer is usually no: it is typically not passed down from a parent and is rarely passed on to children. That patchy gene change also helps explain why the condition tends to affect specific bones and nearby muscles or other soft tissues instead of the whole body.
Is Mazabraud syndrome genetic?
Genetics matter in Mazabraud syndrome, but it is usually not inherited. Many cases are linked to a change in the GNAS gene that happens after conception, so family members are rarely affected.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of being human and are common across the general population. Most of these changes do not directly affect health and simply reflect natural human diversity. For many genes, having a change associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-understood change in a particular gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Mazabraud syndrome, treatment is usually shaped by day-to-day problems such as bone pain, fractures, or a soft-tissue lump that makes movement uncomfortable, rather than by a drug-gene test. Most cases are linked to a change in a gene called GNAS that happens after conception and is found only in the affected tissues, so it is usually not inherited and does not usually tell doctors how your whole body will process medicine. Not every difference in response is genetic, but in Mazabraud syndrome the main known gene change helps explain why the bone and muscle growths develop, not which medication will work best. Doctors may use pain relievers, surgery for bothersome intramuscular myxomas, and sometimes bone medicines such as bisphosphonates for fibrous dysplasia symptoms, but there is no well-established pharmacogenetic test that routinely directs these choices. In practice, the best treatment options for Mazabraud syndrome are still based mostly on symptoms, imaging results, and careful follow-up over time.
Interactions with other conditions
People living with Mazabraud syndrome often deal with two linked problems at once: areas of abnormal bone growth, called fibrous dysplasia, and soft-tissue lumps known as intramuscular myxomas. Day-to-day, it can feel like one health issue amplifies the other, because bone pain, limping, or fractures from fibrous dysplasia may happen in the same part of the body as a nearby muscle lump, which can add discomfort or make walking and daily movement harder. Mazabraud syndrome is also closely related to a condition called McCune-Albright syndrome, since both involve similar changes in the same gene, but McCune-Albright usually brings hormone problems and skin pigment changes that are not typical in Mazabraud syndrome. In rare cases, the bone changes can become more serious and form a bone cancer, so new severe pain, a fast-growing swelling, or a clear change from someone’s usual symptoms needs prompt medical review. Many living with Mazabraud syndrome need follow-up from more than one specialist, because treatment decisions for bone disease, surgery, pain care, and imaging can affect each other. If you are wondering about early symptoms of Mazabraud syndrome or how it overlaps with other bone conditions, regular check-ins can help doctors track changes over time and sort out which problem is causing which symptom.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Mazabraud syndrome?
Mazabraud syndrome can look a lot like fibrous dysplasia on its own, which can also cause bone pain, weak bones, fractures, limping, and changes in bone shape. The soft lumps in muscle may be mistaken for more common problems such as a lipoma, which is a harmless fatty lump, a cyst, or, less often, another kind of soft-tissue growth. Doctors may also think about McCune-Albright syndrome, a related condition that can affect the bones too, but it usually also causes hormone problems and changes in skin color.
History
People living with Mazabraud syndrome often spend years dealing with what seem like two separate problems: unusual bone changes found on scans and soft, slow-growing lumps in the muscles. That link was not clear at first, so early cases were usually described piece by piece rather than as one recognizable condition.
In recent decades, awareness has grown that Mazabraud syndrome is a rare but distinct pattern in which fibrous dysplasia of bone appears alongside intramuscular myxomas, which are noncancerous soft tissue growths. The syndrome is named after French physician A. Mazabraud, who helped bring attention to this combination in the mid-20th century after earlier scattered reports had described similar findings. As medical imaging improved, doctors became better at noticing that these muscle lumps were not random and could occur in the same people who had long-standing bone lesions.
That change mattered in everyday care. Someone might have had bone pain, a limp, or repeated fractures for years, then later notice a painless lump in the thigh or arm. Once doctors recognized the pattern, it became easier to connect these findings instead of treating them as unrelated problems.
Over time, the way the condition has been understood has changed, and that has helped make diagnosis more accurate. Researchers later identified a genetic cause in general terms, which supported what careful clinical observation had already suggested: Mazabraud syndrome is a real biologic syndrome, not just a chance overlap of two uncommon conditions. Today, although it remains rare, doctors are more likely to consider it when reviewing the early symptoms of Mazabraud syndrome and when a person with fibrous dysplasia develops a new soft tissue mass.